Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does HYALURONIDASE-OYSK\TRASTUZUMAB Cause Off label use? 17 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Off label use have been filed in association with HYALURONIDASE-OYSK\TRASTUZUMAB. This represents 22.7% of all adverse event reports for HYALURONIDASE-OYSK\TRASTUZUMAB.

17
Reports of Off label use with HYALURONIDASE-OYSK\TRASTUZUMAB
22.7%
of all HYALURONIDASE-OYSK\TRASTUZUMAB reports
1
Deaths
0
Hospitalizations

How Dangerous Is Off label use From HYALURONIDASE-OYSK\TRASTUZUMAB?

Of the 17 reports, 1 (5.9%) resulted in death.

Is Off label use Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for HYALURONIDASE-OYSK\TRASTUZUMAB. However, 17 reports have been filed with the FAERS database.

What Other Side Effects Does HYALURONIDASE-OYSK\TRASTUZUMAB Cause?

No adverse event (24) Injection site pain (6) Neuropathy peripheral (5) Product storage error (5)

What Other Drugs Cause Off label use?

RITUXIMAB (39,751) INFLIXIMAB (34,801) DENOSUMAB (34,612) METHOTREXATE (24,020) VEDOLIZUMAB (21,017) ETANERCEPT (20,178) TOCILIZUMAB (18,256) PREDNISONE (17,867) LENALIDOMIDE (17,017) ADALIMUMAB (16,417)

Related Pages

HYALURONIDASE-OYSK\TRASTUZUMAB Full Profile All Off label use Reports All Drugs Causing Off label use HYALURONIDASE-OYSK\TRASTUZUMAB Demographics